264 related articles for article (PubMed ID: 32912662)
1. Current Indications for Transoral Robotic Surgery in Oropharyngeal Cancer.
Parhar HS; Yver CM; Brody RM
Otolaryngol Clin North Am; 2020 Dec; 53(6):949-964. PubMed ID: 32912662
[TBL] [Abstract][Full Text] [Related]
2. Open Versus Robotic Surgery for Oropharyngeal Cancer.
Jefferson GD; Frey H
Otolaryngol Clin North Am; 2020 Dec; 53(6):995-1003. PubMed ID: 32854946
[TBL] [Abstract][Full Text] [Related]
3. The Role of Transoral Robotic Surgery in the Management of HPV Negative Oropharyngeal Squamous Cell Carcinoma.
Sload R; Silver N; Jawad BA; Gross ND
Curr Oncol Rep; 2016 Sep; 18(9):53. PubMed ID: 27469262
[TBL] [Abstract][Full Text] [Related]
4. Management of Recurrent and Metastatic HPV-Positive Oropharyngeal Squamous Cell Carcinoma after Transoral Robotic Surgery.
Sims JR; Van Abel K; Martin EJ; Lohse CM; Price DL; Olsen KD; Moore EJ
Otolaryngol Head Neck Surg; 2017 Jul; 157(1):69-76. PubMed ID: 28374634
[TBL] [Abstract][Full Text] [Related]
5. Functional outcomes, feasibility, and safety of resection of transoral robotic surgery: single-institution series of 35 consecutive cases of transoral robotic surgery for oropharyngeal squamous cell carcinoma.
Lörincz BB; Möckelmann N; Busch CJ; Knecht R
Head Neck; 2015 Nov; 37(11):1618-24. PubMed ID: 24955923
[TBL] [Abstract][Full Text] [Related]
6. Transoral robotic versus open surgical approaches to oropharyngeal squamous cell carcinoma by human papillomavirus status.
Ford SE; Brandwein-Gensler M; Carroll WR; Rosenthal EL; Magnuson JS
Otolaryngol Head Neck Surg; 2014 Oct; 151(4):606-11. PubMed ID: 25049265
[TBL] [Abstract][Full Text] [Related]
7. Transoral robotic surgery for oropharyngeal squamous cell carcinoma in the era of human papillomavirus.
Mahmoud O; Sung K; Civantos FJ; Thomas GR; Samuels MA
Head Neck; 2018 Apr; 40(4):710-721. PubMed ID: 29244238
[TBL] [Abstract][Full Text] [Related]
8. Transoral robotic surgery for oropharyngeal carcinoma: Surgical margins and oncologic outcomes.
Moore EJ; Van Abel KM; Price DL; Lohse CM; Olsen KD; Jackson RS; Martin EJ
Head Neck; 2018 Apr; 40(4):747-755. PubMed ID: 29327784
[TBL] [Abstract][Full Text] [Related]
9. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.
Howard J; Dwivedi RC; Masterson L; Kothari P; Quon H; Holsinger FC
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012939. PubMed ID: 30550641
[TBL] [Abstract][Full Text] [Related]
10. Outcomes following TORS for HPV-positive oropharyngeal carcinoma: PEGs, tracheostomies, and beyond.
Van Abel KM; Quick MH; Graner DE; Lohse CM; Price DL; Price KAR; Ma DJ; Moore EJ
Am J Otolaryngol; 2019; 40(5):729-734. PubMed ID: 31303455
[TBL] [Abstract][Full Text] [Related]
11. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.
Howard J; Masterson L; Dwivedi RC; Riffat F; Benson R; Jefferies S; Jani P; Tysome JR; Nutting C
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010963. PubMed ID: 27943254
[TBL] [Abstract][Full Text] [Related]
12. The Role of Surgery in the Management of Recurrent Oropharyngeal Cancer.
Gross ND; Hanna EY
Recent Results Cancer Res; 2017; 206():197-205. PubMed ID: 27699540
[TBL] [Abstract][Full Text] [Related]
13. Transoral robotic retropharyngeal node dissection in oropharyngeal squamous cell carcinoma: Patterns of metastasis and functional outcomes.
Troob S; Givi B; Hodgson M; Mowery A; Gross ND; Andersen PE; Clayburgh D
Head Neck; 2017 Oct; 39(10):1969-1975. PubMed ID: 28758272
[TBL] [Abstract][Full Text] [Related]
14. Transoral robotic surgery and oropharyngeal cancer: a literature review.
O'Leary P; Kjærgaard T
Ear Nose Throat J; 2014 Aug; 93(8):E14-21. PubMed ID: 25181669
[TBL] [Abstract][Full Text] [Related]
15. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation.
Dhanireddy B; Burnett NP; Sanampudi S; Wooten CE; Slezak J; Shelton B; Shelton L; Shearer A; Arnold S; Kudrimoti M; Gal TJ
Am J Otolaryngol; 2019; 40(5):673-677. PubMed ID: 31201038
[TBL] [Abstract][Full Text] [Related]
16. The impact of socioeconomic and geographic factors on access to transoral robotic/endoscopic surgery for early stage oropharyngeal malignancy.
Groysman M; Yi SK; Robbins JR; Hsu CC; Julian R; Bauman JE; Baker A; Wang SJ; Bearelly S
Am J Otolaryngol; 2022; 43(1):103243. PubMed ID: 34583290
[TBL] [Abstract][Full Text] [Related]
17. The role of transoral robotic surgery in the management of oropharyngeal squamous cell carcinoma: a current review.
Sansoni ER; Gross ND
Curr Oncol Rep; 2015 Mar; 17(3):432. PubMed ID: 25687805
[TBL] [Abstract][Full Text] [Related]
18. Transoral robotic surgery for oropharyngeal squamous cell carcinoma.
Schmitt NC; Duvvuri U
Curr Opin Otolaryngol Head Neck Surg; 2015 Apr; 23(2):127-31. PubMed ID: 25692632
[TBL] [Abstract][Full Text] [Related]
19. Oropharyngeal cancer treatment: the role of transoral surgery.
Hinni ML; Nagel T; Howard B
Curr Opin Otolaryngol Head Neck Surg; 2015 Apr; 23(2):132-8. PubMed ID: 25761152
[TBL] [Abstract][Full Text] [Related]
20. Oncological outcomes post transoral robotic surgery (TORS) for HPV-associated oropharyngeal squamous cell carcinoma, a single-centre retrospective Australian study.
Kornfeld B; Taha A; Kyang L; Sim HW; Dewhurst S; McCloy R; Chin V; Earls P; Parker A; Leavers B; Forstner D; Floros P; Crawford J; Gallagher R
J Robot Surg; 2024 May; 18(1):226. PubMed ID: 38806847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
